PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.09%
Revenue growth under 50% of META's 16.05%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.56%
Gross profit growth under 50% of META's 17.62%. Michael Burry would be concerned about a severe competitive disadvantage.
-37.09%
Negative EBIT growth while META is at 32.28%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-37.09%
Negative operating income growth while META is at 32.28%. Joel Greenblatt would press for urgent turnaround measures.
-35.05%
Negative net income growth while META stands at 27.17%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-35.90%
Negative EPS growth while META is at 26.42%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-35.90%
Negative diluted EPS growth while META is at 26.92%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.16%
Share count expansion well above META's 0.30%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.21%
Diluted share count expanding well above META's 0.24%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-22.47%
Negative OCF growth while META is at 5.97%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-35.06%
Negative FCF growth while META is at 3.41%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
502.41%
10Y revenue/share CAGR at 50-75% of META's 767.65%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
100.71%
5Y revenue/share CAGR under 50% of META's 401.78%. Michael Burry would suspect a significant competitive gap or product weakness.
58.97%
3Y revenue/share CAGR under 50% of META's 183.05%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
439.77%
10Y OCF/share CAGR under 50% of META's 3361.63%. Michael Burry would worry about a persistent underperformance in cash creation.
64.10%
Below 50% of META's 1311.73%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
28.29%
3Y OCF/share CAGR under 50% of META's 253.21%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
241.60%
Below 50% of META's 1250.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
19.26%
Below 50% of META's 1679.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
2.55%
Below 50% of META's 336.24%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
576.41%
Equity/share CAGR of 576.41% while META is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
115.95%
5Y equity/share CAGR at 50-75% of META's 218.39%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
51.02%
Below 50% of META's 220.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.71%
AR growth well above META's 14.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
42.14%
Inventory growth of 42.14% while META is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
3.39%
Asset growth well under 50% of META's 7.46%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.14%
Under 50% of META's 6.59%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
0.46%
Debt growth of 0.46% while META is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
5.83%
R&D growth drastically higher vs. META's 4.63%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
3.42%
SG&A growth well above META's 3.04%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.